Save Comparison | ![]() Adamas Pharmaceuticals Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders. | ![]() IntelGenx IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. | ![]() Generex Biotechnology Generex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases. | ![]() Opiant Pharmaceuticals Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders. | |
Founding Date | Founding Date 1974 | Founding Date 2002 | Founding Date 2003 | Founding Date N/A | Founding Date 2009 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Toronto, CA HQ Toronto, CA | Locations Emeryville, US HQ | Locations Saint-Laurent, CA HQ | Locations Burlington, CA HQ Miramar, US | Locations Santa Monica, US HQ London, GB Santa Monica, US |
Employees | Employees 5,9321% increase | Employees 1361% increase | Employees 4826% increase | Employees 9200% increase | Employees 2131% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 128.6 m | Valuation ($) 28.6 m | Valuation ($) 42.8 m | Valuation ($) 39 m |
Twitter followers | Twitter followers 2 k | Twitter followers N/A | Twitter followers 1.1 k | Twitter followers 766 | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 1 | Number of tweets (last 30 days) 6 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 3 | Average likes per tweet (last 30 days) 7.2 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 327678 | Alexa Website Rank 150475 | Alexa Website Rank 356125 | Alexa Website Rank 358312 | Alexa Website Rank 331763 |
Employee Rating | Employee Rating N/A | Employee Rating 3.8 | Employee Rating 3.4 | Employee Rating 3 | Employee Rating N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $54.6m (FY, 2019) | Revenue (est.) $742k (FY, 2019) | Revenue (est.) $6.2m (FY, 2019) | Revenue (est.) $40.5m (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods $2.5m (FY, 2019) | Cost of goods N/A | Cost of goods $4.1m (FY, 2019) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $52.2m (FY, 2019) | Gross profit N/A | Gross profit $2.1m (FY, 2019) | Gross profit $40.5m (FY, 2019) |
Net income | Net income N/A | Net income ($105.2m) (FY, 2019) | Net income ($10.7m) (FY, 2019) | Net income ($11m) (FY, 2019) | Net income $11.6m (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 82m | Total funding raised $ 1.7m | Total funding raised N/A | Total funding raised N/A |
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
View companyIntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.
View companyGenerex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases.
View companyOpiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.
View company